Form 4 for FHTX Foghorn Therapeutics Inc.
Accepted 2024-03-12 00:00:00 ET · period of report 2024-03-11 · accession 0001562180-24-002591 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-12 | 2024-03-11 | FHTX | Cavalie Fanny | Chief Strategy, Bus Ops Off | S - Sale | $6.56 | -11.0K | 76.0K | -13% | -$72.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-11 | S | D | 11,000 | $6.56 | 75,992 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $6.50 USD to $6.83 USD; the price reported above reflects the weighted average sale price. |